CME Outfitters to Deliver Acute Coronary Syndrome Symposium: "Using Evidence and Guidelines to Individualize Care for ACS: A Case-Based Symposium" on March 29 in Chicago

Share Article

CME Outfitters announces an upcoming live and interactive symposium titled "Using Evidence and Guidelines to Individualize Care for ACS: A Case-Based Symposium." Offered as a simultaneous symposium and webcast premiering Saturday, March 29, 2008, from 7:00-9:30 p.m. CT, the activity will provide an overview of current and emerging treatment strategies for patients with acute coronary syndrome.

CME Outfitters, LLC, an independent accredited provider of multidisciplinary medical education programming and related healthcare communications services, announces an upcoming live and interactive symposium titled "Using Evidence and Guidelines to Individualize Care for ACS: A Case-Based Symposium." Offered as a live presentation with subsequent online archive and 3 live Q&A opportunities, this activity takes place on March 29, 2008, from 7:00-9:30 p.m., at the Hilton Chicago.

This live symposium is certified for CME credit and the archive will offer physician (CME), nursing (CNE), and pharmacy (CPE) credit. This symposium will provide an overview of current and emerging treatment strategies for patients with acute coronary syndrome.

There is no fee to participate or receive credit for this activity, however, advance registration is requested. You may register online at http://www.cmeoutfitters.com/symposia, or call 877.CME.PROS for more information.

This event is not part of the official ACC Annual Scientific Session and/or the SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit as planned by their Program Committees.

Statement of Need:
Acute coronary syndrome (ACS) affects more than 1.5 million people in the United States each year, and is associated with an increased risk of cardiac death. Prevention of cardiac events in patients with ACS and those with prior myocardial infarction (MI) or stroke is crucial to improving outcomes and preventing death. Yet, almost half of all patients are under-recognized and not adequately managed. The American College of Cardiology/American Heart Association (ACC/AHA) have recently published new treatment guidelines for ACS, yet even when guidelines are incorporated in practice, some issues remain controversial. For instance, dosing and timing of the administration of antithrombotic therapies is not consistent and these factors can impact outcome. Also, clinicians need to know the importance of risk stratification in the management of ACS. In addition, short-term and long-term management strategies for ACS may differ, and there is not yet consensus in the field regarding best practices. Although current antithrombotic agents are effective, there is room for improvement in outcomes. Promising new agents, including PY212 inhibitors, thrombin receptor antagonists, and Factor Xa inhibitors may play a key role in improving patient care. Faculty in this interactive, live, case-based symposium will translate the latest evidence on treatment guidelines and emerging management strategies to improve practice, individualize treatments, and optimize outcomes of patients with ACS.

Moderator:
Christopher P. Cannon, MD
Senior Investigator, TIMI Study Group
Brigham and Women's Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, MA

Faculty:
Robert A. Harrington, MD
Professor of Medicine, Division of Cardiology
Duke University Medical Center
Director, Duke Clinical Research Institute
Durham, NC

Jeffrey L. Anderson, MD, FACC, FAHA, MACP
Associate Chief of Cardiology
Intermountain Medical Center
Co-Director of Cardiac Research
Professor of Internal Medicine
University of Utah
Salt Lake City, UT

Agenda:
7:00-7:30 p.m. - Dinner
7:30-7:50 p.m. - Welcome/Interactive Case Presentation #1, Christopher P. Cannon, MD, Brigham and Women's Hospital
7:50-8:10 p.m. - Treatment Guidelines: Evidence and Application, Jeffrey L. Anderson, MD, LDS Hospital
8:10-8:30 p.m. - Interactive Case Presentation #2, Christopher P. Cannon, MD, Brigham and Women's Hospital
8:30-8:50 p.m. - New Discoveries in Prevention and Management: What is the Evidence?, Robert A. Harrington, MD, Duke Clinical Research Institute
8:50-9:10 p.m. - Interactive Case Presentation #3, Christopher P. Cannon, MD, Brigham and Women's Hospital
9:10-9:30 p.m. - Q&A Session

Learning Objectives:
At the end of this CE activity, participants should be able to:

  • Describe the impact of treatment selection, dosing, and timing of antiplatelet therapies on overall outcomes of patients with acute coronary syndrome
  • Recognize the role of antithrombotic therapy in the prevention and management of acute coronary syndrome according to ACC/AHA guidelines
  • Evaluate emerging therapies in the management of patients with acute coronary syndrome

Target Audience:
LIVE: Cardiologists and other clinicians who treat patients with acute coronary syndrome.
ARCHIVE: Cardiologists, physician assistants, nurses, pharmacists, and other clinicians who treat patients with acute coronary syndrome.

Commercial Support:
CME Outfitters, LLC, gratefully acknowledges an educational grant from Schering-Plough Corporation in support of this CE activity.

Credit Information:
CME Credit (Physicians; live and archive):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CME Outfitters, LLC, designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Note to Physician Assistants: AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA Category I CME credit for the PRA from organizations accredited by ACCME.

CNE Credit (Nurses; archive):
CME Outfitters, LLC, is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

It has been assigned code 6WASUP-PRV-0629. 2.0 contact hours will be awarded upon successful completion.

Note to Nurse Practitioners: The content of this CNE activity pertains to Pharmacology.

CPE Credit (Pharmacists; archive):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 2.0 contact hours (0.2 CEUs)
Universal Program Number: 376-000-08-005-H01-P (recorded programs)

CME certificates will be distributed to participants at the conclusion of the live symposium. Participants in the archive and Q&A sessions held after the live symposium may receive credit and print a certificate online at http://www.cmeoutfitters.com/test.

About CME Outfitters:
CME Outfitters develops and distributes live, recorded, print, and web-based educational activities to thousands of clinicians each year and offers expert accreditation services for non-accredited organizations. For a complete catalog of certified activities, please visit http://www.cmeoutfitters.com or call 877.CME.PROS (877.263.7767).

To view all recent CME Outfitters press releases, visit http://www.cmeoutfitters.com and click on "News" or visit http://www.prweb.com and search for "CME Outfitters."

For current information about this complimentary 2.0 hour CME activity, please visit http://www.cmeoutfitters.com/symposia.

Contact: Christopher Perez
CME Outfitters, LLC
240.243.1303 direct
240.243.1033 fax

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Christopher Perez
Visit website